Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2014 (2014), Article ID 471319, 4 pages
http://dx.doi.org/10.1155/2014/471319
Case Report

Inefficacy or Paradoxical Effect? Uveitis in Ankylosing Spondylitis Treated with Etanercept

1Rheumatology Unit, Department of Medicine, General Hospital of Bolzano, Lorenz Boehler Street No. 5, 39100 Bolzano, Italy
2Rheumatology Unit, Department of Medicine, University of Padova, 35128 Padova, Italy

Received 10 March 2014; Accepted 27 May 2014; Published 4 June 2014

Academic Editor: Edgar M. Carvalho

Copyright © 2014 Bernd Raffeiner et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. A. Khan, “Spondyloarthropathies,” Rheumatic Disease Clinics of North America, vol. 18, no. 1, pp. 1–276, 1992. View at Google Scholar
  2. J. Sieper, J. Braun, M. Rudwaleit, A. Boonen, and A. Zink, “Ankylosing spondylitis: an overview,” Annals of the Rheumatic Diseases, vol. 61, no. 3, pp. iii8–iii18, 2002. View at Google Scholar · View at Scopus
  3. M. Rudwaleit, D. Van Der Heijde, R. Landewé et al., “The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection,” Annals of the Rheumatic Diseases, vol. 68, no. 6, pp. 777–783, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. A. El Maghraoui, “Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications,” European Journal of Internal Medicine, vol. 22, no. 6, pp. 554–560, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Zeboulon, M. Dougados, and L. Gossec, “Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review,” Annals of the Rheumatic Diseases, vol. 67, no. 7, pp. 955–959, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. E. B. Gouveia, D. Elmann, and M. S. de Ávila Morales, “Ankylosing spondylitis and uveitis: overview,” Revista Brasileira de Reumatologia, vol. 52, no. 5, pp. 742–756, 2012. View at Google Scholar
  7. D. Wendling, “Uveitis in seronegative arthritis,” Current Rheumatology Reports, vol. 14, no. 5, pp. 402–408, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. S. H. Laval, A. Timms, S. Edwards et al., “Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci,” American Journal of Human Genetics, vol. 68, no. 4, pp. 918–926, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Muñoz-Fernández, V. Hidalgo, J. Fernández-Melón et al., “Sulfasalazine reduces the number of flares of acute anterior uveitis over a one-year period,” The Journal of Rheumatology, vol. 30, pp. 1277–1279, 2003. View at Google Scholar
  10. J. M. Benitez-Del-Castillo, J. Garcia-Sanchez, T. Iradier, and A. Bañares, “Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis,” Eye, vol. 14, no. 3, pp. 340–343, 2000. View at Google Scholar · View at Scopus
  11. S. Mũoz-Fernández, A. M. García-Aparicio, M. V. Hidalgo et al., “Methotrexate: an option for preventing the recurrence of acute anterior uveitis,” Eye, vol. 23, no. 5, pp. 1130–1133, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. V. M. B. Fiorelli, P. Bhat, and C. Stephen Foster, “Nonsteroidal anti-inflammatory therapy and recurrent acute anterior uveitis,” Ocular Immunology and Inflammation, vol. 18, no. 2, pp. 116–120, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Levy-Clarke and R. Nussenblatt, “Does anti-TNF therapy decrease the incidence of anterior uveitis in patients with ankylosing spondylitis?” Nature Clinical Practice Rheumatology, vol. 2, no. 2, pp. 72–73, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Rudwaleit, E. Rødevand, P. Holck et al., “Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study,” Annals of the Rheumatic Diseases, vol. 68, no. 5, pp. 696–701, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Guignard, L. Gossec, C. Salliot et al., “Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: A Retrospective Study,” Annals of the Rheumatic Diseases, vol. 65, no. 12, pp. 1631–1634, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Sieper, A. Koenig, S. Baumgartner et al., “Analysis of uveitis rates across all etanercept ankylosing spondylitis clinical trials,” Annals of the Rheumatic Diseases, vol. 69, no. 1, pp. 226–229, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. L. L. Lim, F. W. Fraunfelder, and J. T. Rosenbaum, “Do tumor necrosis factor inhibitors cause uveitis? A registry-based study,” Arthritis and Rheumatism, vol. 56, no. 10, pp. 3248–3252, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Wendling, J. Paccou, J.-M. Berthelot et al., “New onset of uveitis during anti-tumor necrosis factor treatment for rheumatic diseases,” Seminars in Arthritis and Rheumatism, vol. 41, no. 3, pp. 503–510, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Savion, S. Oddo, S. Grover, and R. R. Caspi, “Uveitogenic T lymphocytes in the rat: pathogenicity vs. Lymphokine production, adhesion molecules and surface antigen expression,” Journal of Neuroimmunology, vol. 55, no. 1, pp. 35–44, 1994. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Sieper and J. Van Den Brande, “Diverse effects of infliximab and etanercept on T lymphocytes,” Seminars in Arthritis and Rheumatism, vol. 34, no. 5, supplement 1, pp. 23–27, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. A. N. Collamer and D. F. Battafarano, “Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis,” Seminars in Arthritis and Rheumatism, vol. 40, no. 3, pp. 233–240, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. U. Kiltz, F. Heldmann, X. Baraliakos, and J. Braun, “Treatment of ankylosing spondylitis in patients refractory to TNF-inhibition: are there alternatives?” Current Opinion in Rheumatology, vol. 24, no. 3, pp. 252–260, 2012. View at Publisher · View at Google Scholar · View at Scopus